Sphenopalatine ganglion (SPG) blocks: Evidence and implementation for acute migraine treatment in the primary care setting
Open Access
- 21 May 2025
- journal article
- Published by SAGE Publications in The Journal of Medicine Access
- Vol. 9
Abstract
Background: Sphenopalatine ganglion (SPG) blocks may be effective and affordable treatments for acute migraine but are rarely used in the primary care setting, making them inaccessible treatment for those suffering from migraine. Objective: To outline evidence for the use of SPG block in the treatment of acute migraine. To determine the feasibility and effectiveness of primary care in-office and at-home SPG block administration. Methods: A retrospective chart review of patients receiving in-office or at-home SPG block to treat acute migraine was completed. Pre- and post-treatment pain measurements were the primary outcome, along with patient-reported adverse effects. Results: Results from this study revealed that 87% of SPG block administrations (via catheter and atomizer) resulted in pain relief with minimal adverse effects. Methods and materials for catheter and atomizer administration of SPG blocks are outlined, in addition to tips for integrating this service into primary care practices. Conclusions: This study showed that SPG blocks may be administered effectively in primary care settings or at home with proper patient education and are an effective treatment modality to decrease pain associated with acute migraine.Keywords
Funding Information
- National Institute of Neurological Disorders and Stroke (R43NS125643)
This publication has 19 references indexed in Scilit:
- Greater Occipital Nerve Block for Acute Treatment of Migraine Headache: A Large Retrospective Cohort StudyThe Journal of the American Board of Family Medicine, 2018
- Sphenopalatine Ganglion Block in the Management of Chronic HeadachesCurrent Pain and Headache Reports, 2017
- Sphenopalatine Ganglion (SPG): Stimulation Mechanism, Safety, and EfficacyHeadache: The Journal of Head and Face Pain, 2017
- Pathophysiology of Migraine: A Disorder of Sensory ProcessingPhysiological Reviews, 2017
- Efficacy and Safety of Bupivacaine versus Lidocaine in Local Anesthesia of the Nasopharynx: A Meta-analysisAmerican Journal of Rhinology & Allergy, 2016
- A Double‐Blind, Placebo‐Controlled Study of Repetitive Transnasal Sphenopalatine Ganglion Blockade With T x360 ® as Acute Treatment for Chronic MigraineHeadache: The Journal of Head and Face Pain, 2014
- Expert Consensus Recommendations for the Performance of Peripheral Nerve Blocks for Headaches – A Narrative ReviewHeadache: The Journal of Head and Face Pain, 2013
- Pathophysiology of migraineAnnals of Indian Academy of Neurology, 2012
- Possible sites of action of the new calcitonin gene-related peptide receptor antagonistsTherapeutic Advances in Neurological Disorders, 2010
- Nasal route and drug delivery systemsPharmacy World & Science, 2004